0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PVA Foam Embolization Particles Market Research Report 2023
Published Date: February 2023
|
Report Code: QYRE-Auto-9V3215
Home | Market Reports | Health| Pharmacy
Global PVA Foam Embolization Particles Market Insights and Forecast to 2028
BUY CHAPTERS

Global PVA Foam Embolization Particles Market Research Report 2023

Code: QYRE-Auto-9V3215
Report
February 2023
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global PVA Foam Embolization Particles Market

The global PVA Foam Embolization Particles market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for PVA Foam Embolization Particles is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for PVA Foam Embolization Particles is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of PVA Foam Embolization Particles include Cook Medical, Sirtex Medical, Merit Medical, BTG Medical, Boston Scientific, Terumo, HENGRUI Medical, INterface BIOmaterials and Alicon, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PVA Foam Embolization Particles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PVA Foam Embolization Particles.
The PVA Foam Embolization Particles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global PVA Foam Embolization Particles market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PVA Foam Embolization Particles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • Cook Medical
  • Sirtex Medical
  • Merit Medical
  • BTG Medical
  • Boston Scientific
  • Terumo
  • HENGRUI Medical
  • INterface BIOmaterials
  • Alicon

Segment by Type

  • 50μm~350μm
  • 350μm~560μm
  • 560μm~710μm
  • 710μm~1000μm
  • 1000μm~1400μm
  • 1400μm~2000μm

Segment by Application

  • Uterine Fibroid Embolization
  • Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  • Liver Tumor Embolization
  • Trauma Embolization
  • Others

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of PVA Foam Embolization Particles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of PVA Foam Embolization Particles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global PVA Foam Embolization Particles Market Report

Report MetricDetails
Report NameGlobal PVA Foam Embolization Particles Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 PVA Foam Embolization Particles Market Overview
1.1 Product Overview and Scope of PVA Foam Embolization Particles
1.2 PVA Foam Embolization Particles Segment by Type
1.2.1 Global PVA Foam Embolization Particles Market Value Comparison by Type (2023-2029)
1.2.2 50μm~350μm
1.2.3 350μm~560μm
1.2.4 560μm~710μm
1.2.5 710μm~1000μm
1.2.6 1000μm~1400μm
1.2.7 1400μm~2000μm
1.3 PVA Foam Embolization Particles Segment by Application
1.3.1 Global PVA Foam Embolization Particles Market Value by Application: (2023-2029)
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Global PVA Foam Embolization Particles Market Size Estimates and Forecasts
1.4.1 Global PVA Foam Embolization Particles Revenue 2018-2029
1.4.2 Global PVA Foam Embolization Particles Sales 2018-2029
1.4.3 Global PVA Foam Embolization Particles Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PVA Foam Embolization Particles Market Competition by Manufacturers
2.1 Global PVA Foam Embolization Particles Sales Market Share by Manufacturers (2018-2023)
2.2 Global PVA Foam Embolization Particles Revenue Market Share by Manufacturers (2018-2023)
2.3 Global PVA Foam Embolization Particles Average Price by Manufacturers (2018-2023)
2.4 Global PVA Foam Embolization Particles Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of PVA Foam Embolization Particles, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PVA Foam Embolization Particles, Product Type & Application
2.7 PVA Foam Embolization Particles Market Competitive Situation and Trends
2.7.1 PVA Foam Embolization Particles Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PVA Foam Embolization Particles Players Market Share by Revenue
2.7.3 Global PVA Foam Embolization Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PVA Foam Embolization Particles Retrospective Market Scenario by Region
3.1 Global PVA Foam Embolization Particles Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global PVA Foam Embolization Particles Global PVA Foam Embolization Particles Sales by Region: 2018-2029
3.2.1 Global PVA Foam Embolization Particles Sales by Region: 2018-2023
3.2.2 Global PVA Foam Embolization Particles Sales by Region: 2024-2029
3.3 Global PVA Foam Embolization Particles Global PVA Foam Embolization Particles Revenue by Region: 2018-2029
3.3.1 Global PVA Foam Embolization Particles Revenue by Region: 2018-2023
3.3.2 Global PVA Foam Embolization Particles Revenue by Region: 2024-2029
3.4 North America PVA Foam Embolization Particles Market Facts & Figures by Country
3.4.1 North America PVA Foam Embolization Particles Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America PVA Foam Embolization Particles Sales by Country (2018-2029)
3.4.3 North America PVA Foam Embolization Particles Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PVA Foam Embolization Particles Market Facts & Figures by Country
3.5.1 Europe PVA Foam Embolization Particles Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe PVA Foam Embolization Particles Sales by Country (2018-2029)
3.5.3 Europe PVA Foam Embolization Particles Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PVA Foam Embolization Particles Market Facts & Figures by Country
3.6.1 Asia Pacific PVA Foam Embolization Particles Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific PVA Foam Embolization Particles Sales by Country (2018-2029)
3.6.3 Asia Pacific PVA Foam Embolization Particles Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America PVA Foam Embolization Particles Market Facts & Figures by Country
3.7.1 Latin America PVA Foam Embolization Particles Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America PVA Foam Embolization Particles Sales by Country (2018-2029)
3.7.3 Latin America PVA Foam Embolization Particles Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PVA Foam Embolization Particles Market Facts & Figures by Country
3.8.1 Middle East and Africa PVA Foam Embolization Particles Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa PVA Foam Embolization Particles Sales by Country (2018-2029)
3.8.3 Middle East and Africa PVA Foam Embolization Particles Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global PVA Foam Embolization Particles Sales by Type (2018-2029)
4.1.1 Global PVA Foam Embolization Particles Sales by Type (2018-2023)
4.1.2 Global PVA Foam Embolization Particles Sales by Type (2024-2029)
4.1.3 Global PVA Foam Embolization Particles Sales Market Share by Type (2018-2029)
4.2 Global PVA Foam Embolization Particles Revenue by Type (2018-2029)
4.2.1 Global PVA Foam Embolization Particles Revenue by Type (2018-2023)
4.2.2 Global PVA Foam Embolization Particles Revenue by Type (2024-2029)
4.2.3 Global PVA Foam Embolization Particles Revenue Market Share by Type (2018-2029)
4.3 Global PVA Foam Embolization Particles Price by Type (2018-2029)
5 Segment by Application
5.1 Global PVA Foam Embolization Particles Sales by Application (2018-2029)
5.1.1 Global PVA Foam Embolization Particles Sales by Application (2018-2023)
5.1.2 Global PVA Foam Embolization Particles Sales by Application (2024-2029)
5.1.3 Global PVA Foam Embolization Particles Sales Market Share by Application (2018-2029)
5.2 Global PVA Foam Embolization Particles Revenue by Application (2018-2029)
5.2.1 Global PVA Foam Embolization Particles Revenue by Application (2018-2023)
5.2.2 Global PVA Foam Embolization Particles Revenue by Application (2024-2029)
5.2.3 Global PVA Foam Embolization Particles Revenue Market Share by Application (2018-2029)
5.3 Global PVA Foam Embolization Particles Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Cook Medical
6.1.1 Cook Medical Corporation Information
6.1.2 Cook Medical Description and Business Overview
6.1.3 Cook Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Cook Medical PVA Foam Embolization Particles Product Portfolio
6.1.5 Cook Medical Recent Developments/Updates
6.2 Sirtex Medical
6.2.1 Sirtex Medical Corporation Information
6.2.2 Sirtex Medical Description and Business Overview
6.2.3 Sirtex Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sirtex Medical PVA Foam Embolization Particles Product Portfolio
6.2.5 Sirtex Medical Recent Developments/Updates
6.3 Merit Medical
6.3.1 Merit Medical Corporation Information
6.3.2 Merit Medical Description and Business Overview
6.3.3 Merit Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merit Medical PVA Foam Embolization Particles Product Portfolio
6.3.5 Merit Medical Recent Developments/Updates
6.4 BTG Medical
6.4.1 BTG Medical Corporation Information
6.4.2 BTG Medical Description and Business Overview
6.4.3 BTG Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BTG Medical PVA Foam Embolization Particles Product Portfolio
6.4.5 BTG Medical Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Corporation Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Boston Scientific PVA Foam Embolization Particles Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Terumo PVA Foam Embolization Particles Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 HENGRUI Medical
6.6.1 HENGRUI Medical Corporation Information
6.6.2 HENGRUI Medical Description and Business Overview
6.6.3 HENGRUI Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.4.4 HENGRUI Medical PVA Foam Embolization Particles Product Portfolio
6.7.5 HENGRUI Medical Recent Developments/Updates
6.8 INterface BIOmaterials
6.8.1 INterface BIOmaterials Corporation Information
6.8.2 INterface BIOmaterials Description and Business Overview
6.8.3 INterface BIOmaterials PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.8.4 INterface BIOmaterials PVA Foam Embolization Particles Product Portfolio
6.8.5 INterface BIOmaterials Recent Developments/Updates
6.9 Alicon
6.9.1 Alicon Corporation Information
6.9.2 Alicon Description and Business Overview
6.9.3 Alicon PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Alicon PVA Foam Embolization Particles Product Portfolio
6.9.5 Alicon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PVA Foam Embolization Particles Industry Chain Analysis
7.2 PVA Foam Embolization Particles Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PVA Foam Embolization Particles Production Mode & Process
7.4 PVA Foam Embolization Particles Sales and Marketing
7.4.1 PVA Foam Embolization Particles Sales Channels
7.4.2 PVA Foam Embolization Particles Distributors
7.5 PVA Foam Embolization Particles Customers
8 PVA Foam Embolization Particles Market Dynamics
8.1 PVA Foam Embolization Particles Industry Trends
8.2 PVA Foam Embolization Particles Market Drivers
8.3 PVA Foam Embolization Particles Market Challenges
8.4 PVA Foam Embolization Particles Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global PVA Foam Embolization Particles Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global PVA Foam Embolization Particles Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global PVA Foam Embolization Particles Market Competitive Situation by Manufacturers in 2022
    Table 4. Global PVA Foam Embolization Particles Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global PVA Foam Embolization Particles Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global PVA Foam Embolization Particles Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global PVA Foam Embolization Particles Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market PVA Foam Embolization Particles Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of PVA Foam Embolization Particles, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of PVA Foam Embolization Particles, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of PVA Foam Embolization Particles, Product Type & Application
    Table 12. Global Key Manufacturers of PVA Foam Embolization Particles, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global PVA Foam Embolization Particles by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PVA Foam Embolization Particles as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global PVA Foam Embolization Particles Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global PVA Foam Embolization Particles Sales by Region (2018-2023) & (K Units)
    Table 18. Global PVA Foam Embolization Particles Sales Market Share by Region (2018-2023)
    Table 19. Global PVA Foam Embolization Particles Sales by Region (2024-2029) & (K Units)
    Table 20. Global PVA Foam Embolization Particles Sales Market Share by Region (2024-2029)
    Table 21. Global PVA Foam Embolization Particles Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global PVA Foam Embolization Particles Revenue Market Share by Region (2018-2023)
    Table 23. Global PVA Foam Embolization Particles Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global PVA Foam Embolization Particles Revenue Market Share by Region (2024-2029)
    Table 25. North America PVA Foam Embolization Particles Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America PVA Foam Embolization Particles Sales by Country (2018-2023) & (K Units)
    Table 27. North America PVA Foam Embolization Particles Sales by Country (2024-2029) & (K Units)
    Table 28. North America PVA Foam Embolization Particles Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America PVA Foam Embolization Particles Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe PVA Foam Embolization Particles Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe PVA Foam Embolization Particles Sales by Country (2018-2023) & (K Units)
    Table 32. Europe PVA Foam Embolization Particles Sales by Country (2024-2029) & (K Units)
    Table 33. Europe PVA Foam Embolization Particles Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe PVA Foam Embolization Particles Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific PVA Foam Embolization Particles Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific PVA Foam Embolization Particles Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific PVA Foam Embolization Particles Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific PVA Foam Embolization Particles Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific PVA Foam Embolization Particles Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America PVA Foam Embolization Particles Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America PVA Foam Embolization Particles Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America PVA Foam Embolization Particles Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America PVA Foam Embolization Particles Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America PVA Foam Embolization Particles Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa PVA Foam Embolization Particles Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa PVA Foam Embolization Particles Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa PVA Foam Embolization Particles Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa PVA Foam Embolization Particles Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa PVA Foam Embolization Particles Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global PVA Foam Embolization Particles Sales (K Units) by Type (2018-2023)
    Table 51. Global PVA Foam Embolization Particles Sales (K Units) by Type (2024-2029)
    Table 52. Global PVA Foam Embolization Particles Sales Market Share by Type (2018-2023)
    Table 53. Global PVA Foam Embolization Particles Sales Market Share by Type (2024-2029)
    Table 54. Global PVA Foam Embolization Particles Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global PVA Foam Embolization Particles Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global PVA Foam Embolization Particles Revenue Market Share by Type (2018-2023)
    Table 57. Global PVA Foam Embolization Particles Revenue Market Share by Type (2024-2029)
    Table 58. Global PVA Foam Embolization Particles Price (USD/Unit) by Type (2018-2023)
    Table 59. Global PVA Foam Embolization Particles Price (USD/Unit) by Type (2024-2029)
    Table 60. Global PVA Foam Embolization Particles Sales (K Units) by Application (2018-2023)
    Table 61. Global PVA Foam Embolization Particles Sales (K Units) by Application (2024-2029)
    Table 62. Global PVA Foam Embolization Particles Sales Market Share by Application (2018-2023)
    Table 63. Global PVA Foam Embolization Particles Sales Market Share by Application (2024-2029)
    Table 64. Global PVA Foam Embolization Particles Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global PVA Foam Embolization Particles Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global PVA Foam Embolization Particles Revenue Market Share by Application (2018-2023)
    Table 67. Global PVA Foam Embolization Particles Revenue Market Share by Application (2024-2029)
    Table 68. Global PVA Foam Embolization Particles Price (USD/Unit) by Application (2018-2023)
    Table 69. Global PVA Foam Embolization Particles Price (USD/Unit) by Application (2024-2029)
    Table 70. Cook Medical Corporation Information
    Table 71. Cook Medical Description and Business Overview
    Table 72. Cook Medical PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Cook Medical PVA Foam Embolization Particles Product
    Table 74. Cook Medical Recent Developments/Updates
    Table 75. Sirtex Medical Corporation Information
    Table 76. Sirtex Medical Description and Business Overview
    Table 77. Sirtex Medical PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Sirtex Medical PVA Foam Embolization Particles Product
    Table 79. Sirtex Medical Recent Developments/Updates
    Table 80. Merit Medical Corporation Information
    Table 81. Merit Medical Description and Business Overview
    Table 82. Merit Medical PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Merit Medical PVA Foam Embolization Particles Product
    Table 84. Merit Medical Recent Developments/Updates
    Table 85. BTG Medical Corporation Information
    Table 86. BTG Medical Description and Business Overview
    Table 87. BTG Medical PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. BTG Medical PVA Foam Embolization Particles Product
    Table 89. BTG Medical Recent Developments/Updates
    Table 90. Boston Scientific Corporation Information
    Table 91. Boston Scientific Description and Business Overview
    Table 92. Boston Scientific PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Boston Scientific PVA Foam Embolization Particles Product
    Table 94. Boston Scientific Recent Developments/Updates
    Table 95. Terumo Corporation Information
    Table 96. Terumo Description and Business Overview
    Table 97. Terumo PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. Terumo PVA Foam Embolization Particles Product
    Table 99. Terumo Recent Developments/Updates
    Table 100. HENGRUI Medical Corporation Information
    Table 101. HENGRUI Medical Description and Business Overview
    Table 102. HENGRUI Medical PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. HENGRUI Medical PVA Foam Embolization Particles Product
    Table 104. HENGRUI Medical Recent Developments/Updates
    Table 105. INterface BIOmaterials Corporation Information
    Table 106. INterface BIOmaterials Description and Business Overview
    Table 107. INterface BIOmaterials PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. INterface BIOmaterials PVA Foam Embolization Particles Product
    Table 109. INterface BIOmaterials Recent Developments/Updates
    Table 110. Alicon Corporation Information
    Table 111. Alicon Description and Business Overview
    Table 112. Alicon PVA Foam Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Alicon PVA Foam Embolization Particles Product
    Table 114. Alicon Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. PVA Foam Embolization Particles Distributors List
    Table 118. PVA Foam Embolization Particles Customers List
    Table 119. PVA Foam Embolization Particles Market Trends
    Table 120. PVA Foam Embolization Particles Market Drivers
    Table 121. PVA Foam Embolization Particles Market Challenges
    Table 122. PVA Foam Embolization Particles Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of PVA Foam Embolization Particles
    Figure 2. Global PVA Foam Embolization Particles Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global PVA Foam Embolization Particles Market Share by Type in 2022 & 2029
    Figure 4. 50μm~350μm Product Picture
    Figure 5. 350μm~560μm Product Picture
    Figure 6. 560μm~710μm Product Picture
    Figure 7. 710μm~1000μm Product Picture
    Figure 8. 1000μm~1400μm Product Picture
    Figure 9. 1400μm~2000μm Product Picture
    Figure 10. Global PVA Foam Embolization Particles Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 11. Global PVA Foam Embolization Particles Market Share by Application in 2022 & 2029
    Figure 12. Uterine Fibroid Embolization
    Figure 13. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
    Figure 14. Liver Tumor Embolization
    Figure 15. Trauma Embolization
    Figure 16. Others
    Figure 17. Global PVA Foam Embolization Particles Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 18. Global PVA Foam Embolization Particles Market Size (2018-2029) & (US$ Million)
    Figure 19. Global PVA Foam Embolization Particles Sales (2018-2029) & (K Units)
    Figure 20. Global PVA Foam Embolization Particles Average Price (USD/Unit) & (2018-2029)
    Figure 21. PVA Foam Embolization Particles Report Years Considered
    Figure 22. PVA Foam Embolization Particles Sales Share by Manufacturers in 2022
    Figure 23. Global PVA Foam Embolization Particles Revenue Share by Manufacturers in 2022
    Figure 24. The Global 5 and 10 Largest PVA Foam Embolization Particles Players: Market Share by Revenue in 2022
    Figure 25. PVA Foam Embolization Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 26. Global PVA Foam Embolization Particles Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 27. North America PVA Foam Embolization Particles Sales Market Share by Country (2018-2029)
    Figure 28. North America PVA Foam Embolization Particles Revenue Market Share by Country (2018-2029)
    Figure 29. U.S. PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Canada PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Europe PVA Foam Embolization Particles Sales Market Share by Country (2018-2029)
    Figure 32. Europe PVA Foam Embolization Particles Revenue Market Share by Country (2018-2029)
    Figure 33. Germany PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. France PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. U.K. PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Italy PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Russia PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Asia Pacific PVA Foam Embolization Particles Sales Market Share by Region (2018-2029)
    Figure 39. Asia Pacific PVA Foam Embolization Particles Revenue Market Share by Region (2018-2029)
    Figure 40. China PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Japan PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. South Korea PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. India PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Australia PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Taiwan PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Indonesia PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Thailand PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Malaysia PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Philippines PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Latin America PVA Foam Embolization Particles Sales Market Share by Country (2018-2029)
    Figure 51. Latin America PVA Foam Embolization Particles Revenue Market Share by Country (2018-2029)
    Figure 52. Mexico PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Brazil PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Argentina PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Middle East & Africa PVA Foam Embolization Particles Sales Market Share by Country (2018-2029)
    Figure 56. Middle East & Africa PVA Foam Embolization Particles Revenue Market Share by Country (2018-2029)
    Figure 57. Turkey PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Saudi Arabia PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 59. U.A.E PVA Foam Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 60. Global Sales Market Share of PVA Foam Embolization Particles by Type (2018-2029)
    Figure 61. Global Revenue Market Share of PVA Foam Embolization Particles by Type (2018-2029)
    Figure 62. Global PVA Foam Embolization Particles Price (USD/Unit) by Type (2018-2029)
    Figure 63. Global Sales Market Share of PVA Foam Embolization Particles by Application (2018-2029)
    Figure 64. Global Revenue Market Share of PVA Foam Embolization Particles by Application (2018-2029)
    Figure 65. Global PVA Foam Embolization Particles Price (USD/Unit) by Application (2018-2029)
    Figure 66. PVA Foam Embolization Particles Value Chain
    Figure 67. PVA Foam Embolization Particles Production Process
    Figure 68. Channels of Distribution (Direct Vs Distribution)
    Figure 69. Distributors Profiles
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36H8345
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34R905
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2R9930
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34L14446
Mon Apr 15 00:00:00 UTC 2024

Add to Cart